Sequencing Abiraterone and Enzalutamide in mCRPC

Clinical trial NCT02125357 · COMPLETED

Trial details

NCT number

NCT02125357

Sponsor

British Columbia Cancer Agency

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-09-01

Primary completion

2020-02-04

Enrollment

202

View on ClinicalTrials.gov